Efficacy and Safety of Orally Administered Acotiamide Extended-Release Tablets Among Functional Dyspepsia-Postprandial Distress Syndrome Patients: A Randomized, Double-Blind, Multicenter Study

Background: Acotiamide, is the world's first-in-class, prokinetic drug and world’s first approved treatment for postprandial distress syndrome (PDS) symptoms of functional dyspepsia (FD). An extended-release (ER) formulation of this drug product, developed first-time in the world has been evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinha, Shubhadeep D, Sinha, Saroj K, Talluri, Leela, Bhashyakarla, Ramesh K, Malladi, Umadevi, Dosi, Rupal V, Jain, Mukesh K, Chary, Sreenivasa, Reddy, Mohan, Thakur, Pankaj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Family/General Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098008/
https://www.ncbi.nlm.nih.gov/pubmed/33968542
http://dx.doi.org/10.7759/cureus.14361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098008/
https://www.ncbi.nlm.nih.gov/pubmed/33968542
http://dx.doi.org/10.7759/cureus.14361

Ejemplares similares